| LIPC-AS1 |
|
LIPC antisense RNA 1
|
|
|
0.839 |
0.154 |
19
|
7 |
| ADAMTS9-AS2 |
|
ADAMTS9 antisense RNA 2
|
|
|
0.656 |
0.462 |
18
|
17 |
| BORCS7-ASMT |
|
BORCS7-ASMT readthrough (NMD candidate)
|
|
|
0.805 |
0.154 |
18
|
15 |
| LINC00598 |
|
long intergenic non-protein coding RNA 598
|
|
|
0.743 |
0.192 |
17
|
13 |
| PKN2-AS1 |
|
PKN2 antisense RNA 1
|
|
|
0.769 |
0.385 |
17
|
21 |
| LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
17
|
15 |
| MEF2C-AS1 |
|
MEF2C antisense RNA 1
|
|
|
0.861 |
0.154 |
17
|
31 |
| ZMIZ1-AS1 |
|
ZMIZ1 antisense RNA 1
|
|
|
0.780 |
0.115 |
16
|
7 |
| LINC00511 |
|
long intergenic non-protein coding RNA 511
|
|
|
0.638 |
0.423 |
16
|
8 |
| CCND2-AS1 |
|
CCND2 antisense RNA 1
|
|
|
0.760 |
0.154 |
16
|
7 |
| LINC02341 |
|
long intergenic non-protein coding RNA 2341
|
|
|
0.751 |
0.231 |
16
|
13 |
| LINC01505 |
|
long intergenic non-protein coding RNA 1505
|
|
|
0.821 |
0.192 |
15
|
25 |
| SPRY4-AS1 |
|
SPRY4 antisense RNA 1
|
|
|
0.890 |
0.192 |
15
|
15 |
| VLDLR-AS1 |
|
VLDLR antisense RNA 1
|
|
|
0.821 |
0.115 |
14
|
11 |
| CASC8 |
|
cancer susceptibility 8
|
|
|
0.670 |
0.462 |
14
|
17 |
| CADM3-AS1 |
|
CADM3 antisense RNA 1
|
|
|
1.000 |
0.038 |
14
|
8 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
14
|
10 |
| OBI1-AS1 |
|
OBI1 antisense RNA 1
|
|
|
0.792 |
0.115 |
14
|
6 |
| LINC01475 |
|
long intergenic non-protein coding RNA 1475
|
|
|
0.780 |
0.077 |
14
|
6 |
| LINC01250 |
|
long intergenic non-protein coding RNA 1250
|
|
|
0.743 |
0.231 |
14
|
1 |
| LINC00993 |
|
long intergenic non-protein coding RNA 993
|
|
|
0.729 |
0.269 |
14
|
1 |
| AQP4-AS1 |
|
AQP4 antisense RNA 1
|
|
|
0.751 |
0.577 |
13
|
15 |
| LINC01185 |
|
long intergenic non-protein coding RNA 1185
|
|
|
0.743 |
0.346 |
13
|
10 |
| MIR29B2CHG |
|
MIR29B2 and MIR29C host gene
|
|
|
0.839 |
0.192 |
13
|
12 |